| Very early prophylactic thyroid surgery for infants with a mutation of the RET proto-oncogene at codon 634: evaluation of the implementation of international guidelines for MEN type 2 in a single centre. | thyroid, |
| An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. | thyroid, |
| Expression of ret proto-oncogene in human neuroblastomas. | neuroblastoma, |
| The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. | PCPG,thyroid, |
| [Thyroid carcinomas and Hirschsprung s disease--10-year experience with molecular genetic testing of the RET proto-oncogene]. | thyroid, |
| Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients. | thyroid, |
| Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. | thyroid, |
| RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy. | thyroid, |
| RET proto-oncogene genotyping using unlabeled probes, the masking technique, and amplicon high-resolution melting analysis. | skin, |
| The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma. | neuroblastoma, |
| Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene. | PCPG,kidney, |
| Mutations in the RET proto-oncogene in medullary thyroid carcinoma. | thyroid, |
| MEK inhibition restores NIS protein levels and NIS-mediated radioiodide uptake activity in RET/PTC oncogene-transformed thyroid cells. | thyroid, |
| Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid. | neuroblastoma, |
| RET proto-oncogene expression of papillary thyroid carcinomas in Thai patients. | thyroid, |
| Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene. | PCPG,kidney, |
| Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression. | thyroid, |
| Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. | thyroid, |
| Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas. | thyroid, |
| Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development. | thyroid, |